A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07276958 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Systemic Lupus Erythematosus
Rheumatoid Arthritis

Interventions

DRUG: LY4298445
DRUG: LY4298445

Sponsor

Eli Lilly and Company